KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Pension (2019 - 2020)

Vir Biotechnology (VIR) has disclosed Pension for 2 consecutive years, with $2.9 million as the latest value for Q4 2020.

  • Quarterly Pension rose 52.63% to $2.9 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $2.9 million through Dec 2020, up 52.63% year-over-year, with the annual reading at $2.9 million for FY2020, 52.63% up from the prior year.
  • Pension hit $2.9 million in Q4 2020 for Vir Biotechnology, up from $1.9 million in the prior quarter.
  • In the past five years, Pension ranged from a high of $2.9 million in Q4 2020 to a low of $1.9 million in Q4 2019.